Asprin and Extended-Release Dipyridamole
1 NDC across 1 manufacturer|1 Generic,0 Brand
▸ More about this market▾ Less
Asprin and Extended-Release Dipyridamole is available as 1 NDC from 1 manufacturer (1 generic, 0 brand), with NADAC prices from $0.56 to $0.56 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
1G / 0B
Manufacturers
1
competing in market
Price Spread
$0.56 – $0.56
per EA
7d Activity
avg -0.1% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Glenmark Pharmaceuticals Inc., USA manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Platelet Aggregation Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing ASPRIN AND EXTENDED-RELEASE DIPYRIDAMOLE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
ASPIRIN-DIPYRIDAM ER 25-200 MG | $0.5586 per EA | -0.11% |
Frequently Asked Questions
How many Asprin and Extended-Release Dipyridamole products are on the market?
The Asprin and Extended-Release Dipyridamole drug market contains 1 NDC from 1 manufacturer — 1 generic and 0 brand products.
What is the price range for Asprin and Extended-Release Dipyridamole?
NADAC reference prices for Asprin and Extended-Release Dipyridamole range from $0.5586 to $0.5586 per EA.
Which manufacturers make Asprin and Extended-Release Dipyridamole?
1 manufacturer lists Asprin and Extended-Release Dipyridamole in NADAC. Ranked by number of NDCs, the largest are Glenmark Pharmaceuticals Inc., USA (1).
How has the price of Asprin and Extended-Release Dipyridamole changed recently?
Over the past 7 days, 0 Asprin and Extended-Release Dipyridamole NDCs rose and 3 fell, with a market-wide average change of -0.1%.